Cancer Care Northwest - Spokane Valley ( Site 0036) — Spokane Valley, Washington

Cancer Care Northwest - Spokane Valley ( Site 0036) is a clinical research site located in Spokane Valley, Washington, United States 99216.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Cancer Care Northwest - Spokane Valley ( Site 0036) has participated in 1 clinical trials.

Therapeutic areas: Esophageal Squamous Cell Carcinoma (ESCC), Gastroesophageal Junction Carcinoma (GEJC), Esophageal Adenocarcinoma (EAC).

Sponsors: Merck Sharp & Dohme LLC.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Spokane Valley

Browse all research sites in Washington · View every site in Spokane Valley

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Cancer Care Northwest - Spokane Valley ( Site 0036)?

Cancer Care Northwest - Spokane Valley ( Site 0036) has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Cancer Care Northwest - Spokane Valley ( Site 0036) conducted?

Cancer Care Northwest - Spokane Valley ( Site 0036) has 1 clinical trials on record. Their work covers Esophageal Squamous Cell Carcinoma (ESCC), Gastroesophageal Junction Carcinoma (GEJC), Esophageal Adenocarcinoma (EAC).

Is Cancer Care Northwest - Spokane Valley ( Site 0036) accredited by Crixeo Clinical Trials?

Cancer Care Northwest - Spokane Valley ( Site 0036) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Cancer Care Northwest - Spokane Valley ( Site 0036)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.